The Latest Headlines at BBNS
Quantbot Technologies LP Has $491,000 Stock Holdings in Teekay Corporation Ltd. $TK
Quantbot Technologies LP lifted its position in shares of Teekay Corporation Ltd. (NYSE:TK – Free Report) by 898.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities &... More of this article »
Mcdonald Partners LLC Lowers Stock Position in Meta Platforms, Inc. $META
Mcdonald Partners LLC trimmed its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 73.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange... More of this article »
Kingsview Wealth Management LLC Sells 40,046 Shares of Vanguard Financials ETF $VFH
Kingsview Wealth Management LLC lessened its stake in shares of Vanguard Financials ETF (NYSEARCA:VFH – Free Report) by 93.8% during the third quarter, according to the company in its most recent filing with the Securities and... More of this article »
JT Stratford LLC Purchases 2,462 Shares of JPMorgan Chase & Co. $JPM
JT Stratford LLC raised its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 11.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional... More of this article »
Quantbot Technologies LP Buys 139,439 Shares of Standard Lithium Ltd. $SLI
Quantbot Technologies LP lifted its stake in shares of Standard Lithium Ltd. (NYSEAMERICAN:SLI – Free Report) by 1,531.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor... More of this article »
Quantbot Technologies LP Sells 616,868 Shares of AGNC Investment Corp. $AGNC
Quantbot Technologies LP reduced its holdings in shares of AGNC Investment Corp. (NASDAQ:AGNC – Free Report) by 91.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional... More of this article »
PepsiCo (NASDAQ:PEP) versus Coffee (NASDAQ:JVA) Head-To-Head Contrast
Coffee (NASDAQ:JVA – Get Free Report) and PepsiCo (NASDAQ:PEP – Get Free Report) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their... More of this article »
Comparing TOP Financial Group (NASDAQ:TOP) and The Goldman Sachs Group (NYSE:GS)
TOP Financial Group (NASDAQ:TOP – Get Free Report) and The Goldman Sachs Group (NYSE:GS – Get Free Report) are both finance companies, but which is the superior business? We will compare the two businesses based on the... More of this article »
Brightstar Lottery (NYSE:BRSL) vs. TryHard (NASDAQ:THH) Head-To-Head Comparison
TryHard (NASDAQ:THH – Get Free Report) and Brightstar Lottery (NYSE:BRSL – Get Free Report) are both services companies, but which is the better investment? We will compare the two businesses based on the strength of their... More of this article »
Quantbot Technologies LP Sells 25,825 Shares of iShares Core S&P Small-Cap ETF $IJR
Quantbot Technologies LP reduced its stake in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 85.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange... More of this article »
Quantbot Technologies LP Makes New Investment in iShares U.S. Technology ETF $IYW
Quantbot Technologies LP bought a new position in iShares U.S. Technology ETF (NYSEARCA:IYW – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Quantbot Technologies LP Sells 9,420 Shares of Houlihan Lokey, Inc. $HLI
Quantbot Technologies LP decreased its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI – Free Report) by 76.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 2,921 shares of the... More of this article »
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of DiaMedica Therapeutics, Inc. (NASDAQ:DMAC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst... More of this article »